Cappelleri, Joseph C.
Phase II Clinical Development of New Drugs
1. Introduction
Naitee Ting, Ding-Geng Chen, Shuyen Ho, Joseph C. Cappelleri
2. Concept of Alpha
Naitee Ting, Ding-Geng Chen, Shuyen Ho, Joseph C. Cappelleri
3. Confirmation and Exploration
Naitee Ting, Ding-Geng Chen, Shuyen Ho, Joseph C. Cappelleri
4. Design a Proof of Concept Trial
Naitee Ting, Ding-Geng Chen, Shuyen Ho, Joseph C. Cappelleri
5. Design of Dose-Ranging Trials
Naitee Ting, Ding-Geng Chen, Shuyen Ho, Joseph C. Cappelleri
6. Combining Proof of Concept and Dose-Ranging Trials
Naitee Ting, Ding-Geng Chen, Shuyen Ho, Joseph C. Cappelleri
7. Risks of Inconclusiveness
Naitee Ting, Ding-Geng Chen, Shuyen Ho, Joseph C. Cappelleri
8. Analysis of a Proof of Concept Study
Naitee Ting, Ding-Geng Chen, Shuyen Ho, Joseph C. Cappelleri
9. Data Analysis for Dose-Ranging Trials with Continuous Outcome
Naitee Ting, Ding-Geng Chen, Shuyen Ho, Joseph C. Cappelleri
10. Data Analysis of Dose-Ranging Trials for Binary Outcomes
Naitee Ting, Ding-Geng Chen, Shuyen Ho, Joseph C. Cappelleri
11. Bayesian Approach
Naitee Ting, Ding-Geng Chen, Shuyen Ho, Joseph C. Cappelleri
12. Overview of Phase III Clinical Trials
Naitee Ting, Ding-Geng Chen, Shuyen Ho, Joseph C. Cappelleri
Keywords: Statistics, Statistics for Life Sciences, Medicine, Health Sciences, Pharmaceutical Sciences/Technology, Management
- Author(s)
- Cappelleri, Joseph C.
- Chen, Ding-Geng
- Ho, Shuyen
- Ting, Naitee
- Publisher
- Springer
- Publication year
- 2017
- Language
- en
- Edition
- 1
- Series
- ICSA Book Series in Statistics
- Category
- Natural Sciences
- Format
- Ebook
- eISBN (PDF)
- 9789811041945
- Printed ISBN
- 978-981-10-4192-1